aTyr Pharma competitors

Zippia score 4.0

ATyr Pharma main competitors are Vertex Pharmaceuticals, WebMD, and Merck.

Competitor Summary. See how aTyr Pharma compares to its main competitors:

Merck has the most employees (74,000).
Employees at Vertex Pharmaceuticals earn more than most of the competitors, with an average yearly salary of $95,952.
The oldest company is Merck, founded in 1891.

Work at aTyr Pharma?

Share your experience

aTyr Pharma vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
aTyr Pharma	2005	4.0	San Diego, CA	1	$235,000	44
Regeneron	1988	4.9	Tarrytown, NY	7	$14.2B	9,123
Vertex Pharmaceuticals	1989	4.6	Boston, MA	5	$11.0B	3,400
Merrimack Pharmaceuticals	2000	4.6	Cambridge, MA	1	$102.8M	426
Merck	1891	4.6	Kenilworth, NJ	31	$64.2B	74,000
WebMD	1996	4.7	New York, NY	3	$705.0M	1,800
HHMI	1953	4.7	Chevy Chase, MD	10	$2.4B	1,507
American Association for Cancer Research	1907	3.7	Philadelphia, PA	1	$78.9M	2
American Society for Cell Biology	1960	4.0	Bethesda, MD	1	$10.0M	20
Histogen	2005	4.0	San Diego, CA	1	$17.8M	19
SABPA	2002	3.8	San Diego, CA	1	$62.0M	7,500
MEI Pharma	2000	4.2	San Diego, CA	1	$65.3M	40
Crown Bioscience	2006	3.9	San Diego, CA	3	$12.0M	350
Senomyx	1998	4.3	San Diego, CA	1	$26.4M	56
Protagonist Therapeutics	2006	4.0	Newark, CA	1	$434.4M	118

Rate aTyr Pharma's competitiveness in the market.

aTyr Pharma salaries vs competitors

Among aTyr Pharma competitors, employees at Vertex Pharmaceuticals earn the most with an average yearly salary of $95,952.

Compare aTyr Pharma salaries vs competitors

Company	Average salary	Hourly salary	Salary score
aTyr Pharma	$50,059	$24.07	-
Regeneron	$85,589	$41.15	-
Vertex Pharmaceuticals	$95,952	$46.13	-
Merrimack Pharmaceuticals	$90,170	$43.35	-
Merck	$90,328	$43.43	-
WebMD	$93,501	$44.95	-

Compare aTyr Pharma job title salaries vs competitors

Company	Highest salary	Hourly salary
aTyr Pharma	$33,112	$15.92
American Society for Cell Biology	$43,431	$20.88
Merck	$40,936	$19.68
HHMI	$39,811	$19.14
Vertex Pharmaceuticals	$39,645	$19.06
WebMD	$38,735	$18.62
Merrimack Pharmaceuticals	$36,539	$17.57
Protagonist Therapeutics	$36,409	$17.50
Regeneron	$35,619	$17.12
Histogen	$35,172	$16.91
Senomyx	$34,592	$16.63
American Association for Cancer Research	$33,922	$16.31
Crown Bioscience	$32,939	$15.84
SABPA	$32,299	$15.53
MEI Pharma	$32,035	$15.40

Do you work at aTyr Pharma?

Is aTyr Pharma able to compete effectively with similar companies?

aTyr Pharma jobs

aTyr Pharma demographics vs competitors

Compare gender at aTyr Pharma vs competitors

Job title	Male	Female
Merck	54%	46%
Regeneron	54%	46%
Vertex Pharmaceuticals	56%	44%
Merrimack Pharmaceuticals	56%	44%
Senomyx	68%	32%
aTyr Pharma	-	-

Male

Female

100%

75%

50%

25%

aTyr Pharma

Senomyx

Merrimack Pharmaceuticals

Vertex Pharmaceuticals

Regeneron

Merck

25%

50%

75%

100%

Compare race at aTyr Pharma vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Merck	56%	16%	10%	14%	4%	9.8
Merrimack Pharmaceuticals	67%	10%	7%	12%	4%	9.0
Regeneron	54%	15%	10%	17%	4%	9.8
Senomyx	40%	27%	6%	22%	4%	7.1
Vertex Pharmaceuticals	56%	14%	7%	17%	6%	9.7
HHMI	52%	13%	13%	17%	5%	9.6

aTyr Pharma revenue vs competitors

ATyr Pharma revenue is $235.0K. Among it's competitors, the company with the highest revenue is Merck, $64.2B . The company with the lowest revenue is American Society for Cell Biology, $10.0M.

aTyr Pharma and similar companies CEOs

CEOBio

Steven J. Mento

Histogen

Robert M. Davis

Merck

Robert M. Davis is corporate vice president and president of Baxter's Medical Products business. In this position, Davis oversees a range of products used in the delivery of fluids and drugs to patients, and in the treatment of end-stage kidney disease. Davis took on his current role in October 2010. Prior to this role, Davis served as corporate vice president and president of Baxter's Renal business. He served as corporate vice president and chief financial officer from 2006 through May 2010, and as treasurer from 2004 through 2006. Davis joined Baxter as treasurer in November 2004 from Eli Lilly and Company, where he served in numerous positions of increasing responsibility over 14 years. Davis currently serves on the Board of Trustees for Rush University Medical Center and also serves as a member of the Finance Committee. He also is a member of the Board of Directors of AdvaMed.

Gary L. Crocker

Merrimack Pharmaceuticals

John Poyhonen

Senomyx

Reshma Kewalramani M.d

Vertex Pharmaceuticals

Reshma Kewalramani (born 1973), is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. She is the first female CEO of a large US biotech company. She was previously the chief medical officer and vice president of global medicines development and medical affairs at Vertex.

Robert Brisco

WebMD

Bob Brisco is a Chief Executive Officer at WEBMD HEALTH CORP. and Founder at Classified Ventures and is based in Los Angeles, California. He has worked as President at Universal Citywalk Hollywood, President/CEO at Internet Brands, and President at Universal Studios Hollywood. Robert studied at University of Southern California between 1980 and 1984; University of California, Los Angeles between 1985 and 1987; and UCLA Anderson School of Management between 1985 and 1987.

Shanon Mannie

American Association for Cancer Research

Armin Spura

Crown Bioscience

Armin Spura is a Chief Executive Officer at Crown bioscience.